Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
Innovent Biologics, Inc. (IVBXF)
OTCMKTS
· Delayed Price · Currency is USD
Watchlist
Compare
5.94
0.00 (0.00%)
May 14, 2025, 4:00 PM EDT
Overview
Financials
Statistics
History
Profile
Chart
Income
Balance Sheet
Cash Flow
Ratios
Metrics
NEW
Annual
Revenue by Product
Fiscal year is January - December.
Download
Year Ending
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Dec '20
Dec 31, 2020
Dec '19
Dec 31, 2019
NaN - NaN
Antibody and Protein Medicine, Pharmaceutical Products and Consultation and Research and Development
6.86B
Log In
Log In
Log In
Log In
Upgrade
Antibody and Protein Medicine, Pharmaceutical Products and Consultation and Research and Development Growth
29.43%
Log In
Log In
Log In
Log In
Upgrade
Revenue by Geography
Fiscal year is January - December.
Download
Year Ending
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Dec '20
Dec 31, 2020
Dec '19
Dec 31, 2019
NaN - NaN
China
6.36B
Log In
Log In
Log In
Log In
Upgrade
China Growth
32.29%
Log In
Log In
Log In
Log In
Upgrade
United States
489.07M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
2.32%
Log In
Log In
Log In
Log In
Upgrade
Other
11.19M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-24.88%
Log In
Log In
Log In
Log In
Upgrade
France
-
Log In
Log In
Log In
Log In
Upgrade